Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

DNA DIAGNOSTIC A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   0.6% 0.6% 0.9% 2.0% 0.5% 0.5% 11.6% 11.6%   Credit score (0-100)   98 97 88 68 98 98 21 21   Credit rating   AA AA A A AA AAA BB BB   Credit limit (kDKK)   2,231.3 1,957.8 1,335.2 3.1 2,130.2 2,474.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   10,678 11,521 11,344 10,999 13,846 15,374 0.0 0.0   EBITDA   2,984 2,878 2,069 901 4,632 6,487 0.0 0.0   EBIT   964 330 -489 -1,705 1,514 3,157 0.0 0.0   Pre-tax profit (PTP)   1,068.6 311.8 -551.0 -1,873.2 1,184.9 2,990.8 0.0 0.0   Net earnings   841.0 240.8 -285.6 -1,366.3 1,068.9 2,336.2 0.0 0.0   Pre-tax profit without non-rec. items   1,069 312 -551 -1,873 1,185 2,991 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   2,064 1,740 2,120 1,875 1,554 1,193 0.0 0.0   Shareholders equity total   20,331 18,072 17,787 16,420 17,489 19,826 2,829 2,829   Interest-bearing liabilities   1,126 1,801 2,445 3,405 5,722 5,093 0.0 0.0   Balance sheet total (assets)   27,942 26,651 30,497 33,427 35,996 33,798 2,829 2,829   Net Debt   1,024 1,786 2,433 3,345 4,200 3,543 -2,829 -2,829     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   10,678 11,521 11,344 10,999 13,846 15,374 0.0 0.0   Gross profit growth   -16.0% 7.9% -1.5% -3.0% 25.9% 11.0% -100.0% 0.0%   Employees   12 14 14 15 17 16 0 0   Employee growth %   0.0% 16.7% 0.0% 7.1% 13.3% -5.9% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   27,942 26,651 30,497 33,427 35,996 33,798 2,829 2,829   Balance sheet change%   -0.9% -4.6% 14.4% 9.6% 7.7% -6.1% -91.6% 0.0%   Added value   2,984.2 2,877.5 2,069.3 901.3 4,119.9 6,486.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   906 -2,145 -2,106 -3,420 -3,994 -6,139 -15,861 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 -2.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   9.0% 2.9% -4.3% -15.5% 10.9% 20.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.9% 1.4% -1.6% -5.1% 5.0% 10.2% 0.0% 0.0%   ROI %   4.3% 1.5% -1.9% -6.6% 6.7% 12.8% 0.0% 0.0%   ROE %   4.0% 1.3% -1.6% -8.0% 6.3% 12.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   72.8% 67.8% 58.5% 49.2% 48.8% 58.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   34.3% 62.1% 117.6% 371.1% 90.7% 54.6% 0.0% 0.0%   Gearing %   5.5% 10.0% 13.7% 20.7% 32.7% 25.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.2% 4.5% 4.4% 8.4% 11.7% 10.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.3 0.9 0.6 0.6 1.1 1.7 0.0 0.0   Current Ratio   2.0 1.5 1.2 1.1 1.9 2.8 0.0 0.0   Cash and cash equivalent   101.3 15.4 11.4 60.7 1,522.2 1,550.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   4,105.5 2,171.7 1,753.5 884.7 7,891.1 11,247.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   249 206 148 60 242 405 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   249 206 148 60 272 405 0 0   EBIT / employee   80 24 -35 -114 89 197 0 0   Net earnings / employee   70 17 -20 -91 63 146 0 0